Amedisys AMED

Jump To Section

    $

    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    .
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    +$0.09 (+0.10%)Past DayToday's Volume:
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    ,
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0

    Relative Strength Index (RSI)

    - The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

    - The RSI is calculated using the following formula:

    RSI = 100 - (100 / (1 + RS))

    Where RS is the ratio of the average gains to the average losses over a specified period.

    - The default time period used is 14 days.

    - RSI values range between 0 and 100.

    RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

    RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

    RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

    About

    Business overview of Amedisys (AMED)
    Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, and high acuity care segment. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States; the Hospice segment operates many centers designed to provide comfort and support for terminally ill patients; and the High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.

    Key Insights

    Critical company metrics and information

    • Latest Closing Price

      $92.37

    • Market Cap

      $3.03 Billion

    • Price-Earnings Ratio

      69.98

    • Total Outstanding Shares

      32.81 Million Shares

    • Total Employees

      19,000

    • Dividend

      No dividend

    • IPO Date

      August 17, 1994

    • SIC Description

      Services-home Health Care Services

    • Primary Exchange

      NASDAQ

    • Type

      Common Stock

    • Headquarters

      3854 american way, Baton rouge, LA, 70816

    • Homepage

      https://www.amedisys.com

    Historical Stock Splits

    If you bought 1 share of AMED before December 5, 2006, you'd have 1.33 shares today.
    Execution DateSplit Amount
    December 5, 20064-for-3

    Cash Flow Statement

    January 1, 2024 to December 31, 2024
    MetricValue
    Net Cash Flow From Investing Activities, Continuing$-8.36 Million
    Net Cash Flow From Operating Activities$221.66 Million
    Net Cash Flow$164.38 Million
    Net Cash Flow From Financing Activities$-48.92 Million
    Net Cash Flow From Financing Activities, Continuing$-48.92 Million
    Net Cash Flow, Continuing$164.38 Million

    Income Statement

    January 1, 2024 to December 31, 2024
    MetricValue
    Benefits Costs and Expenses$2.26 Billion
    Depreciation and Amortization$18.00 Million
    Income/Loss From Continuing Operations After Tax$38.16 Million
    Diluted Earnings Per Share$1.31
    Cost Of Revenue$1.33 Billion
    Net Income/Loss Attributable To Noncontrolling Interest$-5.07 Million

    Comprehensive Income

    January 1, 2024 to December 31, 2024
    MetricValue
    Comprehensive Income/Loss Attributable To Parent$43.23 Million
    Comprehensive Income/Loss$38.16 Million
    Other Comprehensive Income/Loss$0
    Comprehensive Income/Loss Attributable To Noncontrolling Interest$-5.07 Million

    Balance Sheet

    January 1, 2024 to December 31, 2024
    MetricValue
    Other Current Assets$619.01 Million
    Liabilities$958.75 Million
    Noncurrent Assets$1.51 Billion
    Liabilities And Equity$2.14 Billion
    Other Current Liabilities$322.44 Million
    Long-term Debt$377.30 Million

    Historical Dividends

    Announcement DatePayment DateRecord DateAmountFrequency
    No historical dividends

    Recent Headlines From The Web

    Latest news, press releases, and media coverage about AMED from trusted financial sources
      Boost your savings and earn 4.15% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
      All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

      ⓒ 2025 Financhle. All Rights Reserved.